Results 31 to 40 of about 554,435 (240)

The effect of antineoplastic drugs in a male spontaneous mammary tumor model [PDF]

, 2013
Male breast cancer is a rare disease. The limited number of clinical cases has led to the primary treatments for men being derived from female breast cancer studies.
Beck, Amanda, Faulkner, Emma B., Nguyen, Thu A., Shishido, Stephanie N.   +3 more
core   +2 more sources

Angiogenesis in male breast cancer [PDF]

, 2005
Background Male breast cancer is a rare but aggressive and devastating disease. This disease presents at a later stage and in a more advanced fashion than its female counterpart.
Kanthan Rani, Lawson Joshua, Frangou Evan M   +2 more
core   +2 more sources

Bladder Cancer Metastasis to the Breast in a Male Patient: Imaging Findings on Mammography and Ultrasonography

대한영상의학회지, 2022
Male breast cancer is rare, accounting for approximately 1% of breast cancers. Metastasis from extra-mammary malignancy to the breast in men is extremely rare.
In Na Yoon, Eun Suk Cha, Jeoung Hyun Kim, Jee Eun Lee, Jin Chung   +4 more
doaj   +1 more source

Identification of differentially expressed microRNAs in human male breast cancer

BMC Cancer, 2010
Background The discovery of small non-coding RNAs and the subsequent analysis of microRNA expression patterns in human cancer specimens have provided completely new insights into cancer biology.
Schipper Elisa, Christgen Henriette, Hasemeier Britta, Albat Cord, Otto Benjamin, Streichert Thomas, Lehmann Ulrich, Hille Ursula, Kreipe Hans H, Länger Florian   +9 more
doaj   +1 more source

Skin involvement as the presenting sign of a male breast cancer [PDF]

, 2020
Male breast cancer is a rare disease with an unknown etiopathogenesis.
Alouani, Imane, Bouziane, Mohammed, Dikhaye, Siham, Zerrouki, Nassiba, Zizi, Nada   +4 more
core  

Expression of phosphorylated eIF4E-binding protein 1, but not of eIF4E itself, predicts survival in male breast cancer [PDF]

, 2016
Background: Male breast cancer is rare and treatment is based on data from females. High expression/activity of eukaryotic initiation factor 4E (eIF4E) denotes a poor prognosis in female breast cancer, and the eIF4E pathway has been targeted ...
A Alayev, A De Benedetti, AC Wolff, AM Shaaban, Andrew M Hanby, AS Green, B Culjkovic, B Culjkovic, B Culjkovic, BD Li, Craig D Sayers, DS Hong, E Kreiter, F Pettersson, F Pettersson, F Rojo, G Ribeiro, H Matsuo, I Johansson, I Johansson, I Zlobec, J Baselga, J Tabernero, JJ Gibbons, JR Graff, K Byrnes, K Katayama, KJ Ruddy, KS Norton, LA Korde, LJ Coleman, M Callari, M Laplante, M Parsons, MJ Wheater, N Siddiqui, N Sonenberg, NK Gray, PP Hsu, R Kornegoor, Rebecca A Millican-Slater, RJ Shaw, S Assouline, S Chan, S Deb, S Deb, S Fogh, S Satheesha, S Zhou, Salvatore Piscuoglio, SL Spunt, SV Bratman, SY Sun, Thomas A Hughes, TS Osborne, U Wazir, V Kerekatte, X Zhou   +57 more
core   +2 more sources

Male breast cancer: a clinicopathological study of an Egyptian population (Alexandria experience)

Contemporary Oncology, 2016
Aim of the study : The purpose of this retrospective study is to evaluate the clinicopathological features and treatment results of male breast cancer presented to our tertiary referral center.
Maher Soliman, Marcin Hetnał
doaj   +1 more source

Development of male breast cancer in a patient with prostate cancer during androgen deprivation therapy

IJU Case Reports, 2022
Introduction Male breast cancer accounts for
Hiroya Mizusawa, Akira Komatsu, Yuji Mimura, Toshitaka Maejima   +3 more
doaj   +1 more source

Male breast cancer: is the scenario changing [PDF]

, 2008
Background The overall incidence of male breast cancer is around 1% of all breast cancers and is on the rise. In this review we aim to present various aspects of male breast cancer with particular emphasis on incidence, risk factors, patho-physiology ...
Kulkarni Dhananjay M, Rodrigues Gabriel S, Kaur Kanchan, Contractor Kaiyumars B, Singhal Hemant   +4 more
core   +1 more source

Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: Results from a pooled analysis [PDF]

, 2015
Background: Male breast cancer is a rare malignancy. Despite the lack of prospectively generated data from trials in either the adjuvant or metastatic setting, patients are commonly treated with hormone therapies.
AB Miller, AM Shaaban, BZ Leder, C Bighin, Carla Azzurra Amoreo, Daniele Santini, Domenico Sergi, F Labrie, F Zagouri, F Zagouri, F Zagouri, Franca Belli, GG T’Sjoen, H Eggemann, Isabella Sperduti, J Doyen, J White, JL Hayward, L Lauro Di, L Lauro Di, LA Korde, Laura Pizzuti, Luigi Di Lauro, M Callari, M Lopez, M Lopez, M Maugeri-Saccà, Maddalena Barba, Marcella Mottolese, Marcello Maugeri-Saccà, N Mauras, Patrizia Vici, Ruggero De Maria, SA Burnett-Bowie, SH Giordano, SH Giordano, Valerie Speirs, WF Anderson   +37 more
core   +4 more sources